Park Avenue Securities LLC lifted its holdings in Cardinal Health, Inc. (NYSE:CAH - Free Report) by 6.2% in the second quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 45,101 shares of the company's stock after purchasing an additional 2,646 shares during the quarter. Park Avenue Securities LLC's holdings in Cardinal Health were worth $7,577,000 at the end of the most recent quarter.
Other large investors have also modified their holdings of the company. MassMutual Private Wealth & Trust FSB grew its position in shares of Cardinal Health by 3.6% during the second quarter. MassMutual Private Wealth & Trust FSB now owns 1,767 shares of the company's stock worth $297,000 after buying an additional 62 shares in the last quarter. Pinnacle Bancorp Inc. lifted its holdings in shares of Cardinal Health by 11.2% in the 1st quarter. Pinnacle Bancorp Inc. now owns 767 shares of the company's stock worth $106,000 after purchasing an additional 77 shares during the last quarter. Thurston Springer Miller Herd & Titak Inc. raised its stake in Cardinal Health by 7.9% during the 2nd quarter. Thurston Springer Miller Herd & Titak Inc. now owns 1,074 shares of the company's stock valued at $181,000 after acquiring an additional 79 shares in the last quarter. Applied Finance Capital Management LLC grew its holdings in shares of Cardinal Health by 1.4% during the first quarter. Applied Finance Capital Management LLC now owns 6,049 shares of the company's stock valued at $833,000 after buying an additional 85 shares in the last quarter. Finally, Perigon Wealth Management LLC lifted its holdings in shares of Cardinal Health by 4.2% during the 1st quarter. Perigon Wealth Management LLC now owns 2,242 shares of the company's stock valued at $309,000 after buying an additional 90 shares during the last quarter. Hedge funds and other institutional investors own 87.17% of the company's stock.
Wall Street Analysts Forecast Growth
A number of research analysts have recently weighed in on CAH shares. Wall Street Zen downgraded Cardinal Health from a "strong-buy" rating to a "buy" rating in a research note on Saturday, August 2nd. UBS Group restated a "buy" rating on shares of Cardinal Health in a research note on Tuesday, August 12th. Wells Fargo & Company reiterated an "overweight" rating and set a $185.00 price target (up previously from $183.00) on shares of Cardinal Health in a research report on Wednesday, August 13th. Evercore ISI reduced their price objective on shares of Cardinal Health from $200.00 to $190.00 and set an "outperform" rating for the company in a research note on Wednesday, August 13th. Finally, Robert W. Baird lifted their price objective on shares of Cardinal Health from $197.00 to $203.00 and gave the company an "outperform" rating in a report on Wednesday, August 13th. Eleven research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average price target of $165.93.
Read Our Latest Stock Report on CAH
Insider Activity at Cardinal Health
In related news, CEO Jason M. Hollar sold 35,901 shares of the firm's stock in a transaction dated Wednesday, August 20th. The stock was sold at an average price of $150.04, for a total value of $5,386,586.04. Following the sale, the chief executive officer directly owned 200,000 shares of the company's stock, valued at $30,008,000. This trade represents a 15.22% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CEO Stephen M. Mason sold 41,575 shares of the business's stock in a transaction that occurred on Tuesday, August 19th. The stock was sold at an average price of $148.82, for a total transaction of $6,187,191.50. Following the completion of the transaction, the chief executive officer owned 26,085 shares of the company's stock, valued at approximately $3,881,969.70. The trade was a 61.45% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 271,676 shares of company stock worth $40,489,525 over the last quarter. 0.12% of the stock is owned by company insiders.
Cardinal Health Stock Performance
Shares of NYSE:CAH traded down $1.99 during trading on Monday, reaching $147.61. 1,987,497 shares of the stock were exchanged, compared to its average volume of 2,018,638. The firm has a market cap of $35.07 billion, a price-to-earnings ratio of 22.89, a price-to-earnings-growth ratio of 1.27 and a beta of 0.73. The firm's 50-day moving average price is $152.78 and its 200 day moving average price is $148.84. Cardinal Health, Inc. has a 12-month low of $106.54 and a 12-month high of $168.44.
Cardinal Health (NYSE:CAH - Get Free Report) last released its quarterly earnings results on Tuesday, August 12th. The company reported $2.08 earnings per share for the quarter, beating analysts' consensus estimates of $2.03 by $0.05. The business had revenue of $60.16 billion during the quarter, compared to analyst estimates of $60.91 billion. Cardinal Health had a negative return on equity of 74.45% and a net margin of 0.70%.Cardinal Health's revenue for the quarter was up .5% on a year-over-year basis. During the same quarter last year, the company posted $1.84 EPS. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. As a group, equities research analysts forecast that Cardinal Health, Inc. will post 7.95 EPS for the current year.
Cardinal Health Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Wednesday, October 15th. Shareholders of record on Wednesday, October 1st will be given a $0.5107 dividend. This represents a $2.04 dividend on an annualized basis and a dividend yield of 1.4%. The ex-dividend date is Wednesday, October 1st. Cardinal Health's payout ratio is 31.63%.
Cardinal Health Profile
(
Free Report)
Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.
See Also
Before you consider Cardinal Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cardinal Health wasn't on the list.
While Cardinal Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
